Patents by Inventor Scott W. Lee

Scott W. Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220031946
    Abstract: Disclosed herein are techniques related to determination of adjustments to fluid delivery settings. In some embodiments, the techniques may involve accessing insulin delivery data for a user of an insulin delivery device. The insulin delivery data may be indicative of an amount of insulin delivered by the insulin delivery device to the user during a time period. The techniques may also involve analyzing the insulin delivery data to generate an updated insulin sensitivity factor (ISF) value. The techniques may further involve generating, based on the updated ISF value, a recommendation to adjust an ISF value of the insulin delivery device. Additionally, the techniques may involve causing adjustment of the ISF value to the updated ISF value in accordance with the recommendation.
    Type: Application
    Filed: October 19, 2021
    Publication date: February 3, 2022
    Inventors: Neha J. Parikh, Anirban Roy, Benyamin Grosman, Patrick E. Weydt, Louis J. Lintereur, Di Wu, Francine R. Kaufman, Scott W. Lee
  • Patent number: 11147919
    Abstract: Disclosed here is a computer-based device and related methodology that manages use of a dual-mode insulin infusion device. The infusion device operates in a manual insulin delivery mode or an automated closed-loop insulin delivery mode. The methodology receives closed-loop pump data for a user of the infusion device, the closed-loop pump data including data indicating basal insulin delivered by the infusion device during operation in the automated closed-loop insulin delivery mode for at least one defined period of time. The methodology analyzes the closed-loop pump data to generate updated basal rate data for the user, and generates, from the updated basal rate data, a recommendation to adjust a manual-mode basal rate setting of the infusion device. In certain scenarios, the infusion device is controlled such that the manual-mode basal rate setting is adjusted in accordance with the recommendation.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: October 19, 2021
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Neha J. Parikh, Anirban Roy, Benyamin Grosman, Patrick E. Weydt, Louis J. Lintereur, Di Wu, Francine R. Kaufman, Scott W. Lee
  • Publication number: 20190321551
    Abstract: Disclosed here is a computer-based device and related methodology that manages use of a dual-mode insulin infusion device. The infusion device operates in a manual insulin delivery mode or an automated closed-loop insulin delivery mode. The methodology receives closed-loop pump data for a user of the infusion device, the closed-loop pump data including data indicating basal insulin delivered by the infusion device during operation in the automated closed-loop insulin delivery mode for at least one defined period of time. The methodology analyzes the closed-loop pump data to generate updated basal rate data for the user, and generates, from the updated basal rate data, a recommendation to adjust a manual-mode basal rate setting of the infusion device. In certain scenarios, the infusion device is controlled such that the manual-mode basal rate setting is adjusted in accordance with the recommendation.
    Type: Application
    Filed: April 23, 2018
    Publication date: October 24, 2019
    Inventors: Neha J. Parikh, Anirban Roy, Benyamin Grosman, Patrick E. Weydt, Louis J. Lintereur, Di Wu, Francine R. Kaufman, Scott W. Lee
  • Publication number: 20100174553
    Abstract: A method of diabetes analysis is provided. A plurality of glucose level readings for a user is received. The plurality of blood glucose level readings are analyzed to generate a report. The report includes a first chart along a 24-hour timeline indicating the plurality of glucose level readings, and a second chart having at least one of infusion device settings and active insulin levels corresponding to the 24-hour timeline of the first chart.
    Type: Application
    Filed: December 21, 2009
    Publication date: July 8, 2010
    Applicant: MEDTRONIC MINIMED, INC.
    Inventors: Francine R. Kaufman, Scott W. Lee, Hans K. Wenstad, Gary Cohen, Kenneth C. Ko, Brian T. Kannard, Kenneth W. Cooper, Keith Nogueira, Bradley C. Liang, Rajiv Shah